Summary
Updated Aug 31, 2026
KKR Genetic Disorder L.P. files SEC Form 4 reports at BridgeBio Pharma, Inc. (BBIO). 1 SEC Form 4 filing on record, dated 12 May 2025. Most recent open-market trade: sold $205.20M of BBIO on 12 May 2025. Lifetime open-market sales: $205.20M.
Recent Transactions
1Every recent SEC Form 4 transaction KKR Genetic Disorder L.P. has reported, most recent first.
Trading Pattern
InsiderAlpha's records for KKR Genetic Disorder L.P. go back to 2025: 1 primary Form 4 filing, an average of 0.5 per year. No transaction on record carries a Rule 10b5-1 flag - the filings look discretionary rather than pre-scheduled, which makes their timing more informative as a signal.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies KKR Genetic Disorder L.P. files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Neil Kumar - $53.07M of BBIO open-market activity in the last 12 months
- Jennifer E. Cook - $21.92M of BBIO open-market activity in the last 12 months
- Frank McCormick - $17.25M of BBIO open-market activity in the last 12 months
- Andrew Lo - $6.32M of BBIO open-market activity in the last 12 months
- Andrea Ellis - $5.65M of BBIO open-market activity in the last 12 months
- Hannah Valantine - $4.37M of BBIO open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
What is KKR Genetic Disorder L.P.?
KKR Genetic Disorder L.P. is an investment firm of BridgeBio Pharma, Inc. (BBIO). InsiderAlpha holds 1 primary Form 4 filing for it, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did KKR Genetic Disorder L.P. last file a Form 4?
The only primary Form 4 on record is dated 12 May 2025.
Has KKR Genetic Disorder L.P. been buying or selling stock?
Recorded transactions: 0 open-market purchases and 1 open-market sale ($205.20M) across all tracked filings.
Where can I see all of KKR Genetic Disorder L.P.'s SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow KKR Genetic Disorder L.P. and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial